Replies to post #659 on Nexien BioPharma Inc (NXEN)

[Renegades17]

I'm very optimistic

I own a lot of the stock on a share basis. It's tough to buy at this point, so I'm glad I accumulated most of my position a couple of weeks ago. Right now, the market is only assigning an $8mm market cap. It certainly seems that there should be several times that value in assets that can be monetized in this shell. I doubt that Intiva bought the shell just to sit on it. They own over 88% of the stock so they have a high incentive to see the market cap go a lot higher.

They kept a stub (ie. small portion of the stock) in public hands much like an IPO. The float is so tiny that when they release news on the assets going into the shell, we should see a rapid re-rating of the stock.

This is probably the most asymmetrically skewed (in a positive sense) investment opportunity I've seen in a very long time.